← SynDRA
R-306465
SynDRA canonical compound SYN0020387 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Mechanism of action | HDAC inhibitor |
Mechanisms of action (all sources)
- histone deacetylase inhibitor
Drug classes
- Histone Deacetylase Inhibitors
Cross-references
Synonyms
- R306465
- JNJ-16241199
- N-hydroxy-2-(4-(naphthalen-2-ylsulfonyl)piperazin-1-yl)pyrimidine-5-carboxamide
- 5WD7KK1IIQ
- N-Hydroxy-2-(4-(naphthalen-2-ylsulfonyl)-piperazin-1-yl)pyrimidine-5-carboxamide
- CHEMBL609583
- 5-Pyrimidinecarboxamide, N-hydroxy-2-(4-(2-naphthalenylsulfonyl)-1-piperazinyl)-
- R306465(JNJ-16241199)
- 5-Pyrimidinecarboxamide, N-hydroxy-2-[4-(2-naphthalenylsulfonyl)-1-piperazinyl]- (9CI)
- UNII-5WD7KK1IIQ
- SCHEMBL1663202
- DTXSID00209218
- ZINC3818418
- BDBM50304782
- MFCD13186898
- NSC773264
- AKOS015899841
- N-hydroxy-2-(4-naphthalen-2-ylsulfonylpiperazin-1-yl)pyrimidine-5-carboxamide
- DB12382
- NSC-773264
- N-Hydroxy-2-[4-(2-naphthalenylsulfonyl)-1-piperazinyl]-5-pyrimidinecarboxamide
- NCGC00351481-01
- S10391
- Q27262965
- 5-Pyrimidinecarboxamide,N-hydroxy-2-[4-(2-naphthalenylsulfonyl)-1-piperazinyl]-
- RefChem:178453
- DTXCID20131709
- C19H19N5O4S
- MUTBJZVSRNUIHA-UHFFFAOYSA-N
- orb1705131
- SCHEMBL31237823
- GLXC-90347
- EZA76901
- JNJ16241199
- HY-10226
- DB-352567
- CS-0002506
- NS00069308
- T21324
Look up R-306465 in the interactive SynDRA portal →